Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has received an average recommendation of “Hold” from the nineteen analysts that are currently covering the company, Marketbeat Ratings reports. Thirteen analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $12.44.

TDOC has been the subject of a number of analyst reports. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a research note on Tuesday, August 20th. DA Davidson dropped their price target on Teladoc Health from $12.00 to $8.00 and set a “neutral” rating for the company in a research note on Thursday, August 1st. JPMorgan Chase & Co. dropped their price target on Teladoc Health from $16.00 to $9.00 and set a “neutral” rating for the company in a research note on Monday, August 26th. Piper Sandler dropped their price target on Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Finally, Canaccord Genuity Group dropped their price target on Teladoc Health from $25.00 to $17.00 and set a “buy” rating for the company in a research note on Thursday, August 1st.

Teladoc Health Stock Up 3.0 %

TDOC opened at $7.39 on Friday. Teladoc Health has a fifty-two week low of $6.76 and a fifty-two week high of $23.18. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.62 and a current ratio of 1.66. The company has a market capitalization of $1.26 billion, a P/E ratio of -5.24 and a beta of 0.90. The stock has a fifty day moving average of $8.40 and a 200-day moving average of $11.58.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The company had revenue of $642.44 million during the quarter, compared to the consensus estimate of $649.34 million. On average, equities analysts expect that Teladoc Health will post -0.71 EPS for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, COO Michael Willem Waters sold 6,053 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $49,271.42. Following the transaction, the chief operating officer now directly owns 74,214 shares of the company’s stock, valued at $604,101.96. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Teladoc Health news, COO Michael Willem Waters sold 6,053 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $49,271.42. Following the transaction, the chief operating officer now directly owns 74,214 shares of the company’s stock, valued at $604,101.96. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Thomas Mckinley purchased 7,000 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was acquired at an average cost of $7.57 per share, for a total transaction of $52,990.00. Following the completion of the purchase, the director now owns 31,077 shares of the company’s stock, valued at approximately $235,252.89. The disclosure for this purchase can be found here. Insiders have sold 37,768 shares of company stock worth $298,639 over the last ninety days. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently modified their holdings of TDOC. International Assets Investment Management LLC raised its position in shares of Teladoc Health by 1,777.0% during the fourth quarter. International Assets Investment Management LLC now owns 112,038 shares of the health services provider’s stock worth $2,414,000 after purchasing an additional 106,069 shares during the period. CWM LLC raised its position in Teladoc Health by 31.3% in the 4th quarter. CWM LLC now owns 5,416 shares of the health services provider’s stock valued at $117,000 after buying an additional 1,291 shares during the last quarter. GAMMA Investing LLC purchased a new stake in Teladoc Health in the 4th quarter valued at $41,000. Van ECK Associates Corp raised its position in Teladoc Health by 20.3% in the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock valued at $77,000 after buying an additional 606 shares during the last quarter. Finally, Hexagon Capital Partners LLC raised its position in Teladoc Health by 204.4% in the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after buying an additional 1,065 shares during the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.